CIMAher® · Immunotherapy · Comprehensive Oncology
Breast Cancer Treatment in Cuba
Cuba's Center of Molecular Immunology (CIM) has developed CIMAher (nimotuzumab), an anti-EGFR monoclonal antibody studied in breast cancer and other solid tumors. Combined with Cuba's comprehensive oncology infrastructure, international patients access multidisciplinary breast cancer programs including surgery, radiation, chemotherapy, and immunotherapy through SMC Salud's coordinated services in Havana.
Breast Cancer — Treatment Video
Combating Cancer in Cuba — Comprehensive Oncology
Visual Guide
Understanding breast cancer care in Cuba
See the specialized facilities and patient-centered care that define our breast cancer treatment programs.
Specialized Oncology care in Cuba
Comprehensive international patient coordination in Havana
Clinical Evidence & Outcomes
The science behind breast cancer treatment in Cuba
Our clinical programs are grounded in peer-reviewed research and coordinated with Cuba's biotechnology institutions. Individual results vary and are confirmed during personalized evaluation.
CIMAher® (nimotuzumab)
EGFR-Expressing Breast Cancer
Nimotuzumab is a humanized monoclonal antibody developed by Cuba's Center of Molecular Immunology (CIM) that targets the epidermal growth factor receptor (EGFR). It has been studied in breast cancer and other EGFR-expressing solid tumors, offering an immunotherapy option with a favorable toxicity profile compared to other anti-EGFR agents.
Source: CIM — Center of Molecular Immunology
Comprehensive Oncology Program
Multidisciplinary Breast Cancer Care
Cuba's oncology centers provide comprehensive breast cancer care including surgery, radiation therapy, chemotherapy, hormone therapy, and access to immunotherapy. The multidisciplinary tumor board reviews each international patient case to develop a personalized treatment plan.
Source: SMC Salud — Office of Medical Affairs
International Patient Access
Coordinated Treatment in Havana
International patients receive comprehensive coordination including medical program issuance, visa assistance, airport reception, accommodation, interpreter services, and 24/7 care coordination throughout their breast cancer treatment program in Havana.
Source: SMC Salud — International Patient Services
Outcomes shown reflect published clinical data and aggregate results. Individual results vary based on diagnosis, disease stage, and overall health, and are confirmed during a personalized medical evaluation. This page is for educational purposes and is not a substitute for professional medical advice.
References & Citations
Clinical content on this page is supported by peer-reviewed research and institutional publications. Individual treatment outcomes vary and are confirmed during personalized medical evaluation.
- 1.
World Health Organization. Breast cancer fact sheet. WHO, 2024.
WHO Fact Sheet - 2.
Rodríguez-Presas E, et al. Nimotuzumab in EGFR-expressing solid tumors: clinical development and outcomes. PubMed.
PubMed - 3.
Crombet T, et al. CIMAvax-EGF and Cuban immunotherapy research. Center of Molecular Immunology, Havana.
PubMed - 4.
Cuban Ministry of Public Health (MINSAP). National Cancer Control Program. Havana, Cuba.
Your Treatment Pathway
Breast Cancer Care Pathway
A coordinated, step-by-step pathway from pre-travel preparation through treatment in Cuba and post-departure follow-up.
Initial Inquiry & Records Review
Submit your medical records for expert review by our specialist team. Our international coordinators respond within 24–48 hours with an initial assessment.
- Medical records submission via secure portal
- Case review by specialist medical team
- Initial eligibility assessment
Remote Medical Evaluation
Your case is reviewed by the Cuban medical team. Additional tests or imaging may be requested remotely. A personalized treatment plan is developed and shared with you and your home-country physician.
- Specialist remote consultation
- Additional diagnostics if needed
- Personalized treatment plan issued
Program Issuance & Travel Arrangements
SMC Salud issues your official medical program letter. Our coordinators assist with visa application, flight booking, and accommodation — matched to your treatment program and family needs.
- Medical program letter issued
- Visa application support
- Flight & accommodation arranged
Comprehensive Oncology Program
Admission to the oncology center. Baseline imaging, receptor status confirmation, and multidisciplinary tumor board review. Treatment may include surgery, radiation, chemotherapy, and access to CIMAher (nimotuzumab) immunotherapy where appropriate.
- Baseline oncology assessment & imaging
- Multidisciplinary tumor board review
- Surgery, radiation, chemotherapy & immunotherapy
Treatment Response & Rehabilitation
Regular imaging and tumor marker monitoring. Post-surgical rehabilitation including lymphedema management and physical therapy. Psychological support and survivorship care planning coordinated with your home-country oncologist.
- Imaging & tumor marker tracking
- Post-surgical rehabilitation & lymphedema care
- Survivorship planning & psychological support
Discharge, Report & Follow-up
Comprehensive medical report translated into your language. Take-home medication supply provided. Telemedicine follow-up program arranged so your Cuban medical team stays connected after you return home.
- Translated comprehensive medical report
- Take-home medication supply
- Telemedicine follow-up scheduled
Our Comprehensive Approach
CIMAher® (nimotuzumab)
Anti-EGFR monoclonal antibody developed by CIM, studied in breast cancer and other EGFR-expressing solid tumors.
Comprehensive Evaluation
Oncology review of imaging, biopsy, receptor status (ER/PR/HER2), and prior treatments to build a personalized plan.
Multidisciplinary Tumor Board
Surgical oncologists, medical oncologists, radiation oncologists, and pathologists collaborate on each case.
Surgery & Radiation
Access to surgical oncology (lumpectomy, mastectomy, reconstruction) and modern radiation therapy planning.
Rehabilitation & Support
Physical therapy, lymphedema management, psychological support, and survivorship care.
International Patient Care
Full coordination: medical visa, accommodation, interpretation, and 24/7 support in Havana.
Breast Cancer — Treatment & Medication
Treatment Options Available in Cuba
Cuba offers comprehensive breast cancer programs including surgery, radiation, chemotherapy, hormone therapy, and access to CIMAher® (nimotuzumab), an anti-EGFR monoclonal antibody developed by CIM and studied in breast cancer. Treatment is coordinated by a multidisciplinary tumor board. No therapy guarantees a cure, and not every patient will benefit. Treatment suitability is determined after medical evaluation of receptor status, staging, and overall health.
Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.
Breast Cancer — Required Documents
Documents for Medical Evaluation
Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.
Biopsy / Pathology Report
Confirmed diagnosis with receptor status (ER/PR/HER2)
CT / MRI / PET-CT
Recent staging imaging
Oncology Reports
Specialist consultation and treatment notes
Previous Treatment Records
Surgery, chemotherapy, or radiation history
Current Medications
All medications currently being taken
Recent Laboratory Results
Blood work and tumor markers
Clinical Evidence
Patient Safety
Expert Specialists
International Standards
Frequently Asked Questions
Questions from international patients
Cuba's Center of Molecular Immunology (CIM) has developed CIMAher (nimotuzumab), an anti-EGFR monoclonal antibody that has been studied in breast cancer and other EGFR-expressing solid tumors. Availability for specific breast cancer subtypes depends on the individual case, receptor status, and current treatment protocols. Eligibility is determined during personalized medical evaluation.
Find country-specific information, testimonials, and FAQs for your region.
Could This Treatment Be Right for You?
Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.